LUC00060I2 - - Google Patents

Download PDF

Info

Publication number
LUC00060I2
LUC00060I2 LU00060C LUC00060C LUC00060I2 LU C00060 I2 LUC00060 I2 LU C00060I2 LU 00060 C LU00060 C LU 00060C LU C00060 C LUC00060 C LU C00060C LU C00060 I2 LUC00060 I2 LU C00060I2
Authority
LU
Luxembourg
Application number
LU00060C
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42107420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LUC00060(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of LUC00060I1 publication Critical patent/LUC00060I1/fr
Publication of LUC00060I2 publication Critical patent/LUC00060I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/003—Adding propellants in fluid form to aerosol containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B7/00—Closing containers or receptacles after filling
    • B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
    • B65B7/28—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
    • B65B7/2842—Securing closures on containers
    • B65B7/285—Securing closures on containers by deformation of the closure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
LU00060C 2009-12-23 2018-01-10 LUC00060I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09180671 2009-12-23
PCT/EP2010/070479 WO2011076843A2 (fr) 2009-12-23 2010-12-22 Polythérapie pour bronchopneumopathie chronique obstructive (copd)
EP10799030.1A EP2515855B3 (fr) 2009-12-23 2010-12-22 Polythérapie pour la COPD

Publications (2)

Publication Number Publication Date
LUC00060I1 LUC00060I1 (fr) 2018-01-18
LUC00060I2 true LUC00060I2 (fr) 2018-03-16

Family

ID=42107420

Family Applications (1)

Application Number Title Priority Date Filing Date
LU00060C LUC00060I2 (fr) 2009-12-23 2018-01-10

Country Status (40)

Country Link
US (3) US20110150782A1 (fr)
EP (1) EP2515855B3 (fr)
JP (2) JP5914354B2 (fr)
KR (2) KR20170040392A (fr)
CN (2) CN104055765B (fr)
AR (2) AR079726A1 (fr)
AU (3) AU2010334859A1 (fr)
BR (1) BR112012015337B8 (fr)
CA (1) CA2785321C (fr)
CL (1) CL2012001705A1 (fr)
CO (1) CO6541628A2 (fr)
CY (2) CY1115116T1 (fr)
DK (1) DK2515855T6 (fr)
EA (2) EA021917B1 (fr)
ES (1) ES2468840T7 (fr)
FI (2) FIC20170064I1 (fr)
GE (1) GEP20156311B (fr)
HR (1) HRP20140582T4 (fr)
HU (1) HUS1800001I1 (fr)
IL (1) IL260932B (fr)
LT (1) LTC2515855I2 (fr)
LU (1) LUC00060I2 (fr)
MA (1) MA33823B1 (fr)
MX (1) MX2012006878A (fr)
MY (1) MY156949A (fr)
NL (1) NL300923I2 (fr)
NO (1) NO2018001I1 (fr)
NZ (1) NZ600790A (fr)
PE (2) PE20121396A1 (fr)
PH (1) PH12012501066A1 (fr)
PL (1) PL2515855T6 (fr)
PT (1) PT2515855E (fr)
RS (1) RS53391B2 (fr)
SG (1) SG181868A1 (fr)
SI (1) SI2515855T1 (fr)
TN (1) TN2012000269A1 (fr)
TW (1) TWI495468B (fr)
UA (1) UA113832C2 (fr)
WO (1) WO2011076843A2 (fr)
ZA (1) ZA201204615B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI495468B (zh) * 2009-12-23 2015-08-11 吉斯藥品公司 治療慢性阻塞性肺病（ｃｏｐｄ）之醫藥組成物
CN102665678B (zh) * 2009-12-23 2014-07-02 奇斯药制品公司 用于copd的联合治疗
KR101747474B1 (ko) 2009-12-23 2017-06-14 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 에어로졸 제제
RU2013142268A (ru) * 2011-02-17 2015-03-27 Сипла Лимитед Фармацевтическая композиция
ES2704465T3 (es) * 2011-10-11 2019-03-18 Chiesi Farm Spa Micropartículas cristalinas de un agonista de beta recubierto con un ácido graso
KR20150096371A (ko) * 2012-10-23 2015-08-24 시플라 리미티드 티오트로피움 및 히드로플루오로알칸을 포함하는 약학적 조성물
KR102275904B1 (ko) 2013-07-11 2021-07-13 키에시 파르마슈티시 엣스. 피. 에이. 흡입에 의한 투여를 위한 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제
CN105848642A (zh) * 2013-12-30 2016-08-10 奇斯药制品公司 格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物
WO2015101576A1 (fr) * 2013-12-30 2015-07-09 Chiesi Farmaceutici S.P.A. Composition de solution d'aérosol stable, mise sous pression, de combinaison de bromure de glycopyrronium et de formotérol
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9554992B2 (en) * 2014-06-09 2017-01-31 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
GB201416909D0 (en) * 2014-09-25 2014-11-12 Prosonix Ltd Method of forming concentrated solution
WO2016170518A1 (fr) 2015-04-24 2016-10-27 Glenmark Specialty S.A. Compositions pharmaceutiques comprenant de l'arformotérol et du glycopyrronium
LT3620176T (lt) 2015-11-16 2021-11-10 Chiesi Farmaceutici S.P.A. Inhaliacinių miltelių kompozicijos, apimančios anticholinerginį agentą, kortikosteroidą ir beta adrenerginį agentą, paruošimo būdas
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3436115B1 (fr) 2016-03-31 2021-07-28 Chiesi Farmaceutici S.p.A. Dispositif d'inhalation d'aérosol
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
ES2877575T3 (es) 2016-09-19 2021-11-17 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende salmeterol
EP3922240B1 (fr) * 2016-09-19 2023-06-21 Mexichem Fluor S.A. de C.V. Composition pharmaceutique comprenant du bromide de tiotropium
US10888546B2 (en) 2016-09-19 2021-01-12 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
EP3621590B1 (fr) 2017-05-11 2021-09-01 Chiesi Farmaceutici S.p.A. Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique
MA48620A (fr) * 2017-05-11 2021-04-28 Chiesi Farm Spa Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique
EA202092976A1 (ru) * 2018-06-04 2021-03-16 Люпин Инк. Устойчивые фармацевтические композиции для дозированных ингаляторов под давлением
EP4069189A1 (fr) * 2019-12-02 2022-10-12 Chiesi Farmaceutici S.p.A. Boîte en acier inoxydable pour inhalateurs doseurs sous pression
US20230270754A1 (en) 2020-07-31 2023-08-31 Chemo Research, S.L. Combination therapy for inhalation administration
AU2021356146A1 (en) 2020-10-09 2023-05-04 Chiesi Farmaceutici S.P.A. A pharmaceutical formulation for pressurised metered dose inhaler
US20250302742A1 (en) 2022-05-27 2025-10-02 Chiesi Farmaceutici S.P.A. A pharmaceutical formulation for pressurised metered dose inhaler
EP4531921A1 (fr) 2022-05-27 2025-04-09 Chiesi Farmaceutici S.p.A. Formulation pharmaceutique pour aérosol-doseur sous pression
JP2025517808A (ja) 2022-05-27 2025-06-10 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量噴霧吸入器のための医薬製剤

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
WO1994013262A1 (fr) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Formulations de solutions medicinales aerosol stabilisees
US6585958B1 (en) 1998-07-24 2003-07-01 Jago Research Ag Medicinal aerosol formulations
AU749697B2 (en) * 1998-08-04 2002-07-04 Jagotec Ag Medicinal aerosol formulations
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
IT1317720B1 (it) 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
AU5070100A (en) 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
PT1372608E (pt) 2001-03-30 2008-01-04 Jagotec Ag Formulações de aerossol médicas
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
EP1321159A1 (fr) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Dispositif d'actionnement pour inhalateur doseur pressurisé avec orifices percés par laser
SI3494995T1 (sl) 2002-03-01 2020-08-31 Chiesi Farmaceutici S.P.A. Superfina formulacija formoterola
WO2004054580A1 (fr) 2002-12-16 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Formulations de solutions aux hfc contenant du tiotropium
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
JP4819699B2 (ja) 2004-02-06 2011-11-24 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤
EP1718336B1 (fr) * 2004-02-06 2008-06-25 MEDA Pharma GmbH & Co. KG Nouvelle combinaison d'anticholinergique et de beta-mimetiques pour le traitement de maladies respiratoires
GB0410399D0 (en) 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
EP1616567A1 (fr) 2004-07-16 2006-01-18 Boehringer Ingelheim Pharma GmbH & Co.KG Médicaments comprenant des inhibiteurs de PDE-IV et des sels de glycopyrolate pour l'inhalation
GB0505545D0 (en) 2005-03-17 2005-04-27 Glaxo Group Ltd Inhalation devices
MX2007012084A (es) 2005-03-30 2007-11-21 Schering Corp Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada.
GB0523653D0 (en) 2005-11-21 2005-12-28 Novartis Ag Organic compounds
WO2007015665A1 (fr) 2005-08-01 2007-02-08 Astrazeneca Ab Valve d'inhalateur
GB0523656D0 (en) 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523654D0 (en) 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523655D0 (en) 2005-11-21 2005-12-28 Novartis Ag Organic compounds
DE602006008665D1 (de) 2005-12-21 2009-10-01 Meda Pharma Gmbh & Co Kg Kombination von r,r-glycopyrrolat, rolipram und budesonid zur behandlung von entzündungskrankheiten
GB0613161D0 (en) * 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
EP1894568A1 (fr) * 2006-08-31 2008-03-05 Novartis AG Composées pharmaceutiques destinées au traitement des maladies inflammatoires ou obstructives des bronches
MX2010004262A (es) 2007-10-18 2010-05-14 Stiefel Res Australia Pty Ltd Formulaciones topicas de glicopirrolato.
WO2010144628A2 (fr) * 2009-06-09 2010-12-16 Elevation Pharmaceuticals, Inc. Traitement d'une maladie pulmonaire obstructive chronique par administration de bêta 2 agoniste nébulisé ou d'une combinaison de bêta 2 agoniste nébulisé et d'anticholinergique
CN102665678B (zh) * 2009-12-23 2014-07-02 奇斯药制品公司 用于copd的联合治疗
KR101747474B1 (ko) * 2009-12-23 2017-06-14 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 에어로졸 제제
RU2567040C2 (ru) 2009-12-23 2015-10-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Аэрозольная препаративная форма для лечения по поводу хронического обструктивного легочного заболевания
TWI495468B (zh) * 2009-12-23 2015-08-11 吉斯藥品公司 治療慢性阻塞性肺病（ｃｏｐｄ）之醫藥組成物
KR102275904B1 (ko) * 2013-07-11 2021-07-13 키에시 파르마슈티시 엣스. 피. 에이. 흡입에 의한 투여를 위한 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제
CN105848642A (zh) 2013-12-30 2016-08-10 奇斯药制品公司 格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物
WO2015101576A1 (fr) 2013-12-30 2015-07-09 Chiesi Farmaceutici S.P.A. Composition de solution d'aérosol stable, mise sous pression, de combinaison de bromure de glycopyrronium et de formotérol
US9554992B2 (en) * 2014-06-09 2017-01-31 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
US10098837B2 (en) * 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD

Also Published As

Publication number Publication date
JP2013515696A (ja) 2013-05-09
PL2515855T6 (pl) 2023-12-18
NZ600790A (en) 2014-09-26
HRP20140582T1 (hr) 2014-08-01
EP2515855B1 (fr) 2014-04-02
FI2515855T6 (fi) 2023-06-02
ES2468840T7 (es) 2023-11-29
KR101757951B1 (ko) 2017-07-13
ES2468840T3 (es) 2014-06-17
AU2016234895A1 (en) 2016-10-13
CL2012001705A1 (es) 2012-09-28
CA2785321A1 (fr) 2011-06-30
PE20160853A1 (es) 2016-09-14
MX2012006878A (es) 2012-07-04
EA027778B1 (ru) 2017-08-31
IL260932B (en) 2021-04-29
AR115897A2 (es) 2021-03-10
BR112012015337A2 (pt) 2016-03-15
CY1115116T1 (el) 2016-12-14
LUC00060I1 (fr) 2018-01-18
US11389401B2 (en) 2022-07-19
CN102665679A (zh) 2012-09-12
NL300923I2 (en) 2019-07-22
TN2012000269A1 (en) 2013-12-12
HK1174566A1 (en) 2013-06-14
US20150328144A1 (en) 2015-11-19
US20110150782A1 (en) 2011-06-23
AR079726A1 (es) 2012-02-15
TWI495468B (zh) 2015-08-11
WO2011076843A3 (fr) 2011-12-01
BR112012015337B8 (pt) 2021-05-25
LTC2515855I2 (lt) 2019-05-10
CN104055765A (zh) 2014-09-24
HUS1800001I1 (hu) 2018-02-28
PH12012501066A1 (en) 2016-03-02
JP5914354B2 (ja) 2016-05-11
TW201129359A (en) 2011-09-01
AU2010334859A1 (en) 2012-07-12
SG181868A1 (en) 2012-07-30
AU2016234895B2 (en) 2018-02-01
FIC20170064I1 (fi) 2017-12-29
BR112012015337B1 (pt) 2021-05-04
WO2011076843A2 (fr) 2011-06-30
CN102665679B (zh) 2014-11-26
KR20120103653A (ko) 2012-09-19
US10159645B2 (en) 2018-12-25
AU2018202998A1 (en) 2018-05-17
CO6541628A2 (es) 2012-10-16
PT2515855E (pt) 2014-06-11
KR20170040392A (ko) 2017-04-12
AU2016234895C1 (en) 2026-02-19
ZA201204615B (en) 2013-09-25
UA113832C2 (xx) 2017-03-27
NO2018001I2 (no) 2018-01-10
DK2515855T6 (da) 2023-06-06
CN104055765B (zh) 2016-11-23
EA021917B1 (ru) 2015-09-30
RS53391B (sr) 2014-10-31
DK2515855T3 (da) 2014-06-30
MA33823B1 (fr) 2012-12-03
HK1197036A1 (en) 2015-01-02
CY2017047I2 (el) 2018-04-04
PE20121396A1 (es) 2012-10-24
RS53391B2 (sr) 2023-09-29
PL2515855T3 (pl) 2014-08-29
JP6283388B2 (ja) 2018-02-21
EA201590179A1 (ru) 2015-09-30
LTPA2018001I1 (lt) 2018-02-12
JP2016145239A (ja) 2016-08-12
EP2515855B3 (fr) 2023-05-03
EP2515855A2 (fr) 2012-10-31
CY2017047I1 (el) 2018-04-04
HRP20140582T4 (hr) 2023-06-09
SI2515855T1 (sl) 2014-08-29
GEP20156311B (en) 2015-07-10
CA2785321C (fr) 2018-08-21
NL300923I1 (en) 2018-01-17
NO2018001I1 (no) 2018-01-10
US20190046433A1 (en) 2019-02-14
MY156949A (en) 2016-04-15
EA201290375A1 (ru) 2013-01-30

Similar Documents

Publication Publication Date Title
BE2015C040I2 (fr)
BRPI0925311A2 (fr)
BR112012008195A2 (fr)
BR112012003062A2 (fr)
BRPI0924307A2 (fr)
BR112012008267A2 (fr)
BR112012012396A2 (fr)
BR112012000607A2 (fr)
BR112012003080A2 (fr)
BR122017024704A2 (fr)
BRPI0924534A2 (fr)
BR112012012080A2 (fr)
BR112012009446A2 (fr)
BR112012009797A2 (fr)
BR112012009703A2 (fr)
BRPI1005795A2 (fr)
BR112012010357A2 (fr)
BR122019005883A2 (fr)
BRPI1004942A2 (fr)
BR112012014856A2 (fr)
BR112012000255A2 (fr)
BR112012007672A2 (fr)
BR112012000156A2 (fr)
BR112012007671A2 (fr)
BR112012009404A2 (fr)